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Collagen: a network for regenerative medicine
K. M. Pawelec,a S. M. Bestb and R. E. Cameron*b
The basic building block of the extra-cellular matrix in native tissue is collagen. As a structural protein,
collagen has an inherent biocompatibility making it an ideal material for regenerative medicine. Cellular
response, mediated by integrins, is dictated by the structure and chemistry of the collagen fibers. Fiber
formation, via fibrillogenesis, can be controlled in vitro by several factors: pH, ionic strength, and
collagen structure. After formation, fibers are stabilized via cross-linking. The final bioactivity of collagen
scaﬀolds is a result of both processes. By considering each step of fabrication, scaﬀolds can be tailored
for the specific needs of each tissue, improving their therapeutic potential.
1. Introduction
Regenerative medicine focuses on the idea of, not just healing
tissue after traumatic injury, but restoring the tissue’s native
function. The strides made towards this ambitious goal rely on
combining advances in medicine with biomedical engineering,
a broad field covering diverse topics such as medical imaging,
drug delivery and cell therapies. Biomaterials development
underpins many of these areas, acting to bridge the gap between
therapeutic agents and the body’s natural healing response.
Originally biomaterials were inert, designed to elicit no
response from the immune system.1 With the growth of molecular
and cellular biology, a new ideal for medical materials emerged:
creating materials which can stimulate native tissue regeneration
and restore the original functionality. Constructs of this nature
would not only support the overall function of the tissue, but
also communicate with the body at the cellular level.1 During
healing, one means, by which to communicate to cells, is
through the diverse cues provided by porous biomaterials
scaﬀolds. The interconnected pores of scaﬀolds not only support
and direct cellular in-growth, but can also be functionalized for
drug and growth factor release.2 For this versatility, eﬀorts in
regenerative medicine often utilize scaﬀolds.
Thematerials andmethods used to create scaﬀolds vary greatly.
A promising approach has been to utilize natural biological
polymers, which already have an innate chemistry to communicate
with cells built into the molecule. Of these polymers, collagen is
the most widely used, as it is the major structural component of
native extra cellular matrix (ECM) in living tissue. Many diverse
applications have been found for collagen scaﬀolds by tailoring
their structures, such as osteochondral defects, connective tissues,
adipose tissue and mammary glands to name a few.3–6 The
versatility of collagen scaffolds is due, in part, to the diverse
ways in which the structures can be tuned. The pore
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architecture can be designed to mimic the anisotropic ECM of
native tissues, which is important for tissues such as tendon
andmeniscus.7–11 In addition, isotropic scaffolds can by fabricated
with pore sizes ranging from 90–300 mm, a parameter affecting
cellular in-growth and mechanics, and defined percolation
diameters, which affects cellular infiltration.12–17 As a further
modifier of biological activity, collagen can also be combined
with other polymers, such as chitosan or elastin, which influences
chemical and mechanical properties.18,19
Cellular response to biomaterials is dictated by a combination of
mechanical, architectural and chemical cues from the scaﬀold.
Sensing cues from the environment is a complex and dynamic
process.20 The machinery used by cells, notably a class of trans-
membrane receptors known as integrins, can control many
functions, including diﬀerentiation.21 For tissue engineering
scaﬀolds, tailoring biological response is linked to controlling
the ligands, or cell signalling moieties, which are presented to
cells and react with receptors.
The goal of this review is to examine the formation of
collagen networks and how cellular interactions can be tuned
via these networks. To accomplish this, first the structure of
natural collagen is considered along with network formation,
known as fibrillogenesis. The physical and chemical properties
of collagen fibers are sensitive to many environmental factors,
and the properties of collagen, in turn, influence the number
and type of ligands which are able to elicit a biological response.
Thus, the factors regulating fibrillogenesis can control the
migration, phenotype and proliferation of cells in contact with
the collagen networks. Once fibers and scaﬀolds are formed,
whether in living tissue or a lab setting, they are invariably
modified to enhance mechanical properties, by introducing
covalent bonds, or cross-links, between individual fibrils.
Cross-links can remove cell adhesion ligands during the process
of stabilizing the network. Therefore increasing attention is
being paid to finding strategies which stabilize collagen net-
works while preserving the ligands which make collagen bio-
compatible. With a deeper understanding of how the chemical
environment drives cellular behavior, collagen scaﬀolds will
be one step closer to achieving the goal of regenerative
medicine.
2. Building a network: collagen
fibrillogenesis
Rather than a static environment, cellular function and growth
is driven by the ECM and its characteristics – mechanical,
chemical, and topographical.22–24 Mechanical considerations
such as substrate stiffness can act as a cellular signal and cause
changes to tissues.25 Structural cues, such as pore alignment in
scaffolds, can also influence cell behavior, including migration
and matrix production.9,17 Evidence suggests that cells are
sensitive enough to detect and respond to nano-scale changes
to the system.24 Besides mechanical signals, cells respond to
the chemical composition of the ECM.23 The chemical environment
includes the amount of proteins, ligands, and other network-
associated factors which serve as a guide for cell growth. For
collagen, the ligands which are able to interact with cells are
influenced by the way in which the fibers are formed. The
versatility of collagen fibrillogenesis offers researchers a way to fine
tune tissue engineering scaffolds for specific tissue environments,
especially as the basis of every tissue is a collagen network.
2.1 Collagen: the basic building block
Throughout decades of research, it has been determined that
collagen is not a single molecule, but a large family of molecules.
The defining feature of a collagen is a protein composed of three
polypeptide chains incorporating at least one region with a
repeating amino acid sequence.26 Collagen type I, for example,
has a repeating sequence of glycine-X-Y which forms a right-
handed triple helix. At least 28 diﬀerent types of collagen have
been found thus far, even excluding the proteins with collagenous
regions which have not been called collagen for historical
reasons.26 Within the collagen superfamily, members are further
classified based on their structure and distribution.
The most widespread collagens are the fibrillar collagens,
composed primarily of a triple-helical region with a characteristic
repeating band where fibers connect, known as D-banding.26 A
distribution of D-spacings exist in the body, ranging between
60–70 nm.27 Collagen types I, II, and III all belong to the
fibrillar group of collagens and vary in amino acid composition
and distribution within the body.28 Collagen type I is the most
common, constituting the major structural protein for skin,
tendon and bone.28 Type II, on the other hand, is found almost
exclusively within cartilage.26
While it is often convenient to classify collagens by the
environments where they are most prevalent, many collagens
are incorporated in trace amounts throughout the body.26 For
example, collagen type VI is a constituent of nearly all tissues
and has been implicated in tissue integrity.29 A growing class of
collagens are termed FACITs, or Fibril Associated Collagens
with Interrupted Triple helices.26 Members of this collagen
class associate strongly with collagen fibrils of diﬀerent types
throughout the body, and are believed to have a regulatory role
on fiber dimensions and interactions.30
Given the wide diversity of collagens and the many functions
that the collagens serve, the collagen composition of each
tissue is unique. Within many tissues, mature collagen fibersR. E. Cameron
Ruth Cameron is a Professor of
Materials Science at the University
of Cambridge and, together with
Professor Best directs the
Cambridge Centre for Medical
Materials (CCMM). Research at
CCMM is focused on designing,
creating and characterizing three
dimensional environments for
cells, and with biomaterials and
pharmaceutical materials for
therapeutic application.
Review Journal of Materials Chemistry B
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
2 
A
ug
us
t 2
01
6.
 D
ow
nl
oa
de
d 
on
 1
9/
06
/2
01
7 
14
:0
7:
47
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
6486 | J. Mater. Chem. B, 2016, 4, 6484--6496 This journal is©The Royal Society of Chemistry 2016
are heterotypic with fibrils from multiple collagen types.31 The
composition of collagen ECM changes not only with tissue type,
but also with age. For example, it has been noted that tendon
tissue, which is predominately type I, with traces of types III and
V, has varying amounts of type XII and XIV during development,
suggesting a regulatory function.31 The assembly of heterotypic
collagen fibers is a multi-step process which is exemplified by
assembly of collagen type I fibers.
2.2 Collagen type I fibrillogenesis
Collagen type I fiber formation, termed fibrillogenesis, is a
multi-step process driven by the increase in entropy associated
with increasing molecular disorder at the water–protein
interface.26 Within living tissue, it is known that cells play an
active role in the deposition of a collagen matrix, but the exact
nature of the cellular contribution to the orientation and
properties of the matrix remain an area of active investigation.
Fibrillogenesis also occurs in vitro, although, in general, the
collagen networks formed tend to be composed of fibers in a
random orientation, rather than the highly aligned bundles,
which are normally observed in tissues. The structure of the
collagen is important, as this determines the signals, such as
adhesion ligands, available for cellular signalling. Thus, the
ways in which structure can be modified might be used to
direct cell response.
Fibrillogenesis in tissues. The process of fiber formation begins
with the translation of the collagen protein in the endoplasmic
reticulum. After translation, the peptide is post translationally
modified in several ways, including glycosylation, modification
of residues, and di-sulphide bonding.26 Each collagen molecule
contains extra peptide sequences at both ends of the protein
which are believed to play a role in the initial formation of a
triple helix.32 Once three peptides form a triple helix, the
molecule is called procollagen.33 The end segments are subsequently
removed, and the molecule, often called tropocollagen, is stabilized
by covalent bonding along the chain and can participate in fiber
formation, Fig. 1.26,34
Maturation of fibers occurs in three stages: initial formation
of fibrils, end to end linear growth, and finally, lateral growth.31
All three of these stages occur in the extracellular space, in close
association with cells, although there is still debate over the
relative importance of cellular ordering versus liquid crystal
interactions.26,31,35 Unlike in vitro reactions, which proceed
spontaneously, nucleation of collagen fibers in vivo is dependent
on other molecules, such as fibronectin and collagen type V.36
The final stage of assembly, lateral growth of fibers, is only
observed in mature tissues, and is highly regulated to ensure
that the fiber diameter and orientation are correct.31 Molecules
such as small leucine rich proteins have been shown to associate
closely with collagen fibers to help regulate fiber diameter.37
Fibrillogenesis in vitro. Due in part to the method of harvest,
the collagen used in tissue engineering can be extremely diverse.
Collagen is often harvested from tissues based on its solubility.
The solubility, in turn, depends heavily on the amount of cross-
linking present within the collagen fibers, and can also vary
between diﬀerent tissues.28,38 Procollagen and immature fibrils
are easily solubilized, even in neutral salt solutions, and can be
used to form tissue engineering gels.28 Further processing of the
collagen molecule, during isolation, can remove areas important
for normal D-banding, such as the telomere region, leading to
many alternative packing arrangements.39 The fraction of collagen
which is insoluble is held together with mature cross-links, and is
thus more resistant to proteases than other forms of collagen.28
The number of cross-links which remain in the collagen molecule
can also aﬀect the time to form a stable network. More cross-links
shorten the time for self-assembly.40
It must be noted that a key feature in collagen networks is
the characteristic D-banding formed as the individual fibers
arrange themselves, revealing an ordered packing along the
fiber length. This marks a key diﬀerence between collagen and
gelatin networks, both of which are used in regenerative medicine.
Even though the amino acid sequence is the same, gelatins, or
denatured collagen chains, gel by undergoing a conformational
change from a random coil to an ordered helix.41,42 Within
gelatin gels, only very short segments of triple helices form,
whose length is dependent on gelling conditions.43 With gelatin,
the gel is never in an equilibrium state, but is modified over time,
increasing the number of helices, but never reaching the state of
collagen with D-banding characteristics.
The formation of collagen fibers in vitro, is roughly broken
into two phases: a lag and growth phase. During the lag phase
of fibrillogenesis, collagen fibrils in solution must associate to
form the nucleus of a triple helix structure.44 Nucleation
proceeds in a step wise manner, starting with the formation
of dimers and trimers of collagen fibrils, which then rearrange
to form triple helices. However, at high collagen concentrations,
collagen molecules can first aggregate, in an equilibrium state with
monomers, leading to an elevated local concentration ofmonomers,
Fig. 1 A schematic of the processing stages by which collagen fibers are
formed in vivo, emphasizing the modifications which occur before fibrils
form. Reprinted from ref. 34, copyright 2001, with permission from Elsevier.
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and thus assisting the initial nuclei formation.45 After a critical
number of nuclei are reached, fibrils begin to grow laterally,
eventually yielding fibers with the characteristic D-banding seen
in natural tissues, Fig. 2. The process is often monitored via
turbidity measurements, although other methods, such as rapid
speed scanning atomic force microscopy (AFM) and confocal
reflectance microscopy are being explored.46,47
Helix formation relies heavily on electrostatic interactions
along the collagen fibrils, and thus, it is very sensitive to
environmental factors which can alter the charge along the
molecule: pH or ionic strength of the buﬀer, and the structure
of the collagen molecule itself. At pH values far away from the
isoelectric point of collagen molecules, fibrillogenesis will be
slow or incomplete resulting in a loss of D-banding. In some
cases, no fibrils will form unless additional ions or charge
altering molecules, are present to force fibril formation by
shifting collagen’s isoelectric point.48,49 The eﬀect of pH can
manifest itself as a change in collagen properties, such as
swelling, and alteration of the D-banding.50 In systems with a
dynamic pH, the rate of pH change during fibril formation can
aﬀect the size and order of fibrils formed. With higher rates of
pH change, the molecules spend shorter periods around the
isoelectric point, reducing lateral growth in the fibers.51 When
the rate is reduced, the lateral growth increases, but some of
the D-banding is lost, resulting in a more heterogeneous
population of fibrils.51
In conjunction with pH, the ionic strength of the buﬀer
solution has a profound eﬀect on fibrillogenesis, generally
delaying the onset of nucleation.44 Any ions in solution alter
the isoelectric point of collagen and can bind to charged groups
along the chain, eﬀectively keeping amino acids from participating
in the reaction.52 Salts also can stabilize the collagen triple
helices by screening amino acids or changing how fibrils inter-
act with the water.48,52 The type of ions in the buﬀer also play a
profound role in determining the assembly of collagen, through
changes in the isoelectric point. For example, with an increase from
0.1 mM to 10 mM KCl, the isoelectric point of pepsin-solubilized
collagen type I shifted 7.5 to 5.3, but reached above 9 with the same
amount of CaCl2.
52 Complexity is added when multiple ions are
present in the environment. For example, in phosphate buﬀers,
chloride ions aid fibrillogenesis of acetic acid soluble collagenmuch
better than in water alone.49 In addition, multivalent ions appear to
increase the banding formation through increased charge screening
along the collagen fibril.48 The environment for fibrillogenesis
in vivo is filled with ions and other molecules. Besides their eﬀect
on the stability of collagen fiber formation, they can act asmolecular
crowders to aﬀect many biological processes. In vitro, crowders have
been found to shorten the nucleation time and increase growth
rates of fibers, by reducing the eﬀective space collagen can occupy,
making interactions more likely.53
Not just salts, but largemolecules can also aﬀect fibrillogenesis.
Glycosaminoglycans (GAGs) and small leucine rich proteins
(SLRPs) are common in heterotypic collagen molecules and are
known to play an important role in the regulation of fiber size
in vivo.37,39 These molecules can be incorporated into growing
fibrils during in vitro fibrillogenesis, and their properties
influence the final structure.54 In mixtures of collagen and
hyaluronic acid, it was found that the sulphation state of the
GAG altered the isoelectric point of the final gels formed, and
higher sulphation decreased the fibril size.54 Silicates can also
can interact with collagen fibrils to control nucleation. When
silica nanoparticles were negatively charged, positively charged
collagen fibrils associated with the particles, and formed fibers
as the pH was lowered.55
Fig. 2 Fibrillogenesis of type I collagen at pH 7.4, at a concentration of 30 mg ml1, imaged with fast atomic force microscopy (AFM). The initial
moments are recorded in (A), and subsequent timings in (B and D–I) are measured from this point. First oligomeric intermediates, without D-banding are
formed (B), followed by subsequent fiber formation and lateral growth (D–I). The plot in (C) shows the growth of the collagen fibers, as a measure of
percent coverage from the images, demonstrating the growth kinetics. X-scan size in (A and B) is 2 mm, and (D–I) is 1 mm; Z-height for all images is 3 nm.
Reprinted from ref. 47, copyright 2015, with permission from Elsevier.
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The amino acid sequence of the collagen molecule also
impacts fibrillogenesis in various ways. Packing of the collagen
fibrils relies on changes in amino acid conformation along the
chain.56 A macroscopic eﬀect of the change in structure is
readily seen in the diﬀerent assembly rates of collagen types.
Collagen type III and II form fibrils faster than type I, due to
higher molecular mass of type I and fewer intermolecular
interactions.57 The source of collagen also impacts the amino
acid structure and the biological signals inherent to the fiber.
In fact, the most variable regions between mammalian collagen
chains are the sequences of peptides near protein binding sites,
which might modify specific cell response.58 In addition to
mammalian sources, marine collagen is an attractive alternative,
as it is cheaper and readily available.59 However, collagen from
marine sources has very diﬀerent properties than mammalian
collagen, such as lower melting temperatures, due to higher
content of glutamic acid and alanine rather than proline.59
Bacterial and recombinant collagen proteins are other alter-
natives to mammalian collagen, containing well-defined amino
acid structures which can be modified with additional cell
signalling sequences.60 Despite the advantages, bacterial collagen
has a very low tendency to form fibrils, something which is
believed to be caused by a lack of hydroxyproline residues.60
While infinitely variable, recombinant proteins are generally
limited in size, and thus are closer in nature to gelatins rather
than native collagen fibrils. As such, they cannot recapitulate
the long triple helices of collagen molecules, and thus any cell
adhesive ligands may have an altered conformation in comparison
with those found on collagen fibers.61
2.3 Mature collagen fibers
The formation of fibers is only the first stage in the formation
of a collagen structure within the ECM. Several natural processes
can occur to the fibers over time, most notably cross-linking.
Other modifications to the collagen fiber are typical of disease
states. For example, the citrullination of arginine, which forms
part of cell binding motifs, occurs frequently in rheumatoid
arthritis.62 Even natural cross-linking of the collagen fibers
can play both a beneficial and harmful role, and is divided into
enzymatic and non-enzymatic reactions.
Enzymatic cross-links contribute to the overall biological
function by stabilizing the fibers and improving mechanical
properties. The cross-links are formed via lysyl oxidases (LOX),
copper dependent enzymes, which act on the telopeptide
region of the molecule.63 The enzyme oxidizes lysine residues,
recognizing very specific ligands, generally in the telopeptide
region of themolecule.63Without LOX, themechanical development
of ECM is arrested, and fibers have irregular size and spacing.64 For
collagen structures formed in vitro, the work of LOX is often taken
over via chemical or physical cross-linkers.
After the introduction of enzymatic cross-linkers, non-enzymatic
reactions take place randomly throughout the helices, accumulating
with age. Of the non-enzymatic reactions, glycosylation of the
collagen fibers, at arginine and lysine pairs, is the most common
and leads to advanced end products (AGEs) which can stiﬀen
the matrix.65,66 The AGEs which accumulate often modify the
biological behavior of the collagen fibers by interrupting cell
and protein binding sequences.65 It has been shown that net-
works formed in vitro from collagen incorporating high
amounts of AGEs have a higher viscosity and faster gelation
than collagen from younger sources, and show a decrease in the
proliferation rate of stromal cells.66
3. Cell recognition of collagen
As a key structural component in vivo, collagen has an innate
biocompatibility, making it attractive for regenerative medicine
eﬀorts. Collagen provides many cues to direct cellular behavior.
Adhesive ligands, which are naturally occurring in collagen, are
powerful regulators of cell response. The importance of adhesion
ligands cannot be underestimated. Bone marrow stromal cells
require the presence of adhesion ligands to bind to the substrate,
as shown in alginate systems, which lack the inherent cues of
natural polymers.67 In addition, the control of the ligands
presented to cells has a profound eﬀect on biological responses,
such as cell spreading or stem cell diﬀerentiation, Fig. 3.68,69 It
is the wide range of signals, each of which can be controlled and
fine-tuned to some extent, which make collagen a promising
tool for controlling tissue regeneration.69
Collagen can interact with a variety of cell trans-membrane
receptors, including integrins and discoidin domain receptors
(DDRs).70 One of the most studied class of receptors are the
integrins, which link ECM signals to intracellular events, and
are often associated with the actin cytoskeleton.71 Functional
integrins are composed of two subunits: alpha and beta. The
alpha subunit recognizes the ligand in the ECM, while the beta
subunit generally sets cellular events in motion.72 A range of
alpha and beta subunits exist, which recognize a variety of
ligands, and the downstream eﬀects are often determined by
the particular combination of subunits which are activated.73 Both
the cell type and the developmental stage of the cells influence the
integrin subunits which are present at the cell surface.72
The cellular processes regulated by integrins are diverse and
key to cellular survival, including proliferation, migration and
interaction with growth factors.73,74 Thus the regulation of integrin
binding is extremely important. Regulation can occur by aﬃnities
between the ligand and receptor, integrin clustering, and intra-
cellular movement of the integrin receptors.75 Mechanical
forces also regulate ligand aﬃnities, by stretching areas of the
integrin and transitioning manually from closed to open state
via mechanical means.76 Mechanics, and the mechanism of
mechanosensing is a complex set of interactions, and has been
reviewed elsewhere.20 Even shifting from two-dimensional to
three-dimensional culture systems can aﬀect the expression of
alpha subunits in vitro.74 Regardless of the type of signal, the
downstream eﬀects of integrin binding are mediated by a host
of other molecules and proteins, known collectively as the
adhesome.20
The environment around the cells contains a large number
of cues which can be interpreted by cells and plays a role in
integrin expression. The ligands which integrins recognize are
Journal of Materials Chemistry B Review
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conserved amino acid sequences found in many components
within the ECM.72 One of the most well known of the integrin
ligands is the RGD sequence, found in proteins such as
fibronectin and fibrinogen. In addition to those molecules that
use RGD as their primary mediator of cell response, many
proteins in the ECM contain RGD sequences which only
become accessible after processing or degradation.72 Collagen
is an example of this type of protein, which only reveals an RGD
sequence following denaturation to gelatin. Thus, interactions
with native collagen fibers are not through RGD. Instead collagen
recognition operates via another binding site: GFOGER, which is
dependent on collagen’s helical structure.77 Minor alterations of
this sequence also act as ligands, but GFOGER has the highest
binding aﬃnity, leading to the greatest attachment, Fig. 3.68,78,79
Binding to GFOGER is most commonly through the a1b1 and
a2b1 integrins, while a5, aV, and a8 subunits recognize the RGD
sequence.72
Despite the positive eﬀects of incorporating cell ligands into
biomaterials, the interaction of the ECM and the environment
can also have negative consequences. For example, in a cancerous
environment, the ECM undergoes changes, uncovering some
of the ‘‘hidden’’ ligands along the collagen fibers. This is
especially illustrated by the a11 integrin, which plays a role in
metastasis in cancer. Due to the stiﬀening of the matrix,
collagen reveals a ligand for a11, which is mediated via dis-
coidin domain receptors, and leads to cancer activation and
metastasis.80 For a more detailed treatment of cellular inter-
actions with the ECM in tumor environments, readers are
directed to the recent review by Multhaupt et al.70
The complexity of ligand interactions increases due to the
role of ligand conformation. Surfaces which present RGD in a
cyclic conformation trigger diﬀerent integrin expression than
surfaces with linear RGD.81 Altering the pattern of integrin
activation can aﬀect the composition of focal adhesions at the
surface, changing the force generated by the cell, which can
ultimately influence complex processes like myogenesis.81 Thus,
ligand conformation may be an important aspect to consider
when designing adhesive peptides or transitioning between
collagen and gelatin substrates.
In addition to amino acid sequence, the clustering of
integrins has a large impact on the downstream cellular eﬀects,
increasing signalling eﬀectiveness, independent of the global
density of ligand present, Fig. 3.68 However, in a study with aVb3
integrin binding, it was found that above a certain threshold,
integrins lose the ability to bind their ligands due to over-
crowding.82 Adding to the complexity, cellular processes respond
diﬀerently to ligands. It was demonstrated that adhesion ligands
on surfaces can up-regulate initial attachment but down-regulate
later proliferation, migration and matrix production.83 Studies
with vascular smooth muscle cells show an optimum between 2.8
and 7 mmol ml1 adhesive peptide.83 Heterotypic collagen fibers,
which incorporate a variety of proteins containing diﬀerent
ligands, can therefore deliver highly specific signals through
the type and spacing of signalling ligands. Ligand density acts
independently of matrix stiﬀness to determine the maximum
forces generated by cells during adhesion.84 The way in which
the ligands are anchored in the ECM can also modulate cell
expression. A 2.5 fold diﬀerence in collagen anchoring density
was shown to determine stem cell fate.85 This highlights how
crucial it is to consider the way in which biomaterials present
cellular adhesion ligands to cells. Harnessing the potential
of this complex code will be an important step to advance
regenerative medicine.
4. Harnessing collagen’s potential
Despite the ubiquitous nature of collagens in vivo, harnessing
their potential as biomaterials is an on-going process. The use
of collagen as a biomaterial takes many forms, most commonly
as gels and scaﬀolds. Gels are composed of a collagen fiber
network whose characteristics are dependent on the fibrillo-
genesis conditions. Scaﬀolds incorporate a level of organization
at a larger length scale than gels, and thus oﬀer another layer of
control. Not only can the fibril structure be tuned, but also the
scaﬀold architecture can be manipulated to form either aligned
or isotropic structures of varying pore size.12 The many steps to
form mature collagen fibers give researchers many stages to
tailor the structure and chemistry of collagen materials to meet
Fig. 3 Ligand density of the substrate and ligand aﬃnity aﬀects cellular
adhesion and spreading. (a–d) Hydrogels were patterned with RGD either
(a and c) 49 nm apart or (b and d) 135 nm apart. After 24 hours,
mesenchymal stem cells were stained for cytoskeletal proteins: vinculins
(green), F-actins (red), and nuclei (blue). Micrographs were taken at (a and
b) lowmagnification and (c and d) high magnification (insets show close up
of vinculin at the cell periphery). Adapted with permission from ref. 68.
Copyright 2015 American Chemical Society. (e) The amino acid sequence
of the ligand in collagen type I has a profound effect on the affinity, shown
in the altered spreading of HT1080 cells, visualized via phalloidin staining.
Adapted from ref. 69, with permission.
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their particular needs. These can be roughly divided into
the stage of initial network formation and network stabilization
via cross-linking.
4.1 Tailoring the collagen network
The sensitivity of collagen fibrillogenesis to environmental
conditions make it a natural way to tailor the properties of
the collagen network. Given the wide range of diseases which
are associated with changes in the structure or chemistry of
collagen, it is evident that biological activity is extremely
sensitive to alterations which take place during the events of
fibrillogenesis.86 Indeed, several studies have shown that structural
changes to the collagen fiber alter the biological activity. In gels,
this is often accomplished throughmixtures of collagen with other
molecules.
Creating mixtures of collagen and other polymers, such as
GAGs, has led to a wide range of biomaterials with diﬀering
biological properties. In mixtures of collagen and hyaluronic
acid, it was found that additions of sulphate groups to the
hyaluronic acid led to a decrease in fiber size after fibrillogenesis.54
The extra sulphation also correlated to a decrease in osteoclasto-
genesis.54 However, organic materials are not the only molecules
which can be incorporated into growing collagen fibers. Addition
of oxidized carbon nanotubes alter the physical characteristics of
collagen, such as the D-banding.87 With the incorporation of
nanotubes, the D-banding increased from 67 to 70 nm, and the
stiﬀness of the fibers increased as well. The conformational
change was shown to drive increased neuronal diﬀerentiation of
human decidua parietalis placental stem cells in vitro, compared
to unaltered collagen or gelatin.87 Another possible route for
controlling fibrillogenesis with inorganic materials is to use
particles as nucleators, which has been demonstrated with
silicate nanoparticles which underwent sulphation.55 These exam-
ples from the field of bionanocomposites, centered on the inter-
actions between organic polymers and inorganic colloids, illustrate
the advances in recent years, which are reviewed elsewhere.88
The biological response of collagen gel networks is not always
mediated by cellular response to the fibers. For example, changes
in pH have been found to aﬀect subsequent mineralization in
gels. By adjusting the pH of acid soluble collagen fibrils to 9, prior
to fibrillogenesis, amines along the molecule reacted to produce
ammonia. This allowed the collagen fibers to retain electro-
negative charges that are stable at pH 7, after readjustment.89
The reaction only took place before fibrillogenesis and could
not be induced after the fiber had formed.89 Additional charges
along the fiber acted as extra nucleation sites for intramolecular
mineralization, leading to increased mineral content both
in vitro and in vivo, in a subcutaneous model.89
Tailoring collagen scaﬀolds requires balancing alterations
in the collagen conformation and any possible interactions
with the scaﬀold processing technique. Scaﬀolds made via ice-
templating, for example, rely on the use of ice to create porous
open structures. The resultant structures depend on the formation
and growth of ice, which is, in turn, aﬀected by many of the
same factors which modify fibrillogenesis, most notably pH
and solutes.90,91 Thus, the properties of the ice growth and
collagen conformation both impact the final scaﬀold architecture,
and cell response. These sometimes competing eﬀects can be
observed when the collagen solution is modified during scaﬀold
production.
Scaﬀolds can be made from collagen solubilized in both hydro-
chloric acid (HCl) and acetic acid, but the collagen conformation
and subsequent scaﬀolds is aﬀected by the acid type.16,91 Changes
in viscosity between collagen solutions hydrated in the two acids
suggest that the conformation was altered by the ionic strength
of the acids. In HCl, the collagen solution had a higher viscosity,
and the resulting scaﬀolds had a larger pore size. Other studies
have also demonstrated a change in the percolation diameter,
altering cellular infiltration.16 This structure was better able to
support the proliferation of fibroblast cells.91 While the collagen
fibers were aﬀected by the acid type, the decreased scaﬀold pore size
in acetic acid solutions was most likely dominated by a decrease in
the ice growth rate by the higher concentration of acetic acid
molecules required to achieve the same pH as the HCl solution.
In the case of solute addition during scaﬀold production, it
was found that the properties of the solute are key to determining
whether the changes in collagen conformation or ice growth play
a greater role on the final architecture.92 With non-ionic solutes,
such as sucrose, changes in the scaﬀold structure were due to
alteration of ice growth. Increasing solutes slow ice growth,
leading to scaﬀolds with a smaller pore size.93,94 Ionic solutes,
in this case 0.5 wt% sodium chloride (NaCl), aﬀected the collagen
conformation more than ice growth. In the presence of NaCl, the
collagen became more fibrillar, and the scaﬀold pore walls had a
more fiber-like surface, Fig. 4. The change in conformation is
consistent with the ability of NaCl to stabilize collagen triple
helices, and was also observed in the decreased viscosity of the
collagen slurry, from 36.3 Pa s to 3.2 Pa s, Fig. 4, suggesting the
collagen had fewer entanglements.52 The conformational change
in the collagen was enough to oﬀset the decrease in ice growth
rate caused by salt addition, allowing ice crystals to grow significantly
greater, resulting in larger pores. In conjunction with structural
changes, adhesion of chondrocytes was significantly lowered
with the addition of 0.5 wt% NaCl, highlighting the importance
of collagen conformation on biological activity.92
There is obviously a need to consider the chemical state of
the collagen before creating any matrix for biomedical applications.
The great potential for tailoring the cellular environment via
this approach can be applied to collagen gels relatively easily. In
the case of scaﬀolds, it can be diﬃcult to separate the eﬀects of
scaﬀold processing from collagen conformational changes. This
area of biomaterials design is not emphasized in current literature,
but the obvious biological impact of structural changes makes it an
interesting avenue to explore further. However, once a network
is formed, it must be stabilized, which requires a diﬀerent type
of collagen modification through the use of cross-linkers.
4.2 Modification of chemistry: post network formation
Having discussed the extreme sensitivity of cellular response to
both mechanics and chemical stimulus, it is apparent that any
processes which alter either property must be carefully considered.
The process of stabilizing collagen networks, either gels or
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scaﬀolds, via cross-linking can aﬀect both properties. On one
hand, the covalent cross-linking reactions strengthen the collagen
structure to improve handling, slow degradation, and aid cellular
mechanosensing. On the other hand, many cross-linking treatments
disrupt the cell adhesion ligands necessary for biocompatibility. This
dual nature of cross-linking has been demonstrated, with collagen
films and fibers, where mechanics and the cross-linking chemistry
both influence cellular adhesion.95,96
Cross-linkers aﬀect cells by altering the mechanical environ-
ment, by changing the number or conformation of ligands
present, and possibly by being released as cytotoxic agents
during degradation. It is diﬃcult to separate the eﬀects of
chemistry from scaﬀold mechanics. It has been shown that
both high substrate elasticity and high ligand aﬃnity increase
traction forces exerted by cells and raise the maximum traction
force which can be exerted.84 As integrin bonding is mediated
by mechanosensing and ligand density, biological response to
scaﬀolds is altered.21 Thus, collagen scaﬀold cross-linking can
direct biological responses, such as the diﬀerentiation of
mesenchymal stem cells.97 It is important to note that many
cross-linkers react at amine and carboxylic acid sites, which are
amino acids commonly part of integrin ligands, such as RGD
and GFOGER. The removal of these vital groups can alter
cellular diﬀerentiation, adhesion and migration.98,99 It is there-
fore important to consider the type and amount of cross-linking
which is necessary for each particular application.
One of the key considerations when selecting a cross-linking
method is to ensure that cytotoxic eﬀects of the cross-linker are
minimized. The most well known of the collagen cross-linkers,
glutaraldehyde, has been shown in many studies to be eﬀective
at stabilizing scaﬀolds, but it is associated with a high level
of cytotoxicity which continues over time due to slow removal of
the glutaraldehyde chain during degradation.100,101 This severely
limits the applications where it can be used, and it has been
noted that there is a general lack of cross-linkers for injectable
gels which act quickly enough to stabilize the gel without adverse
eﬀects.102 Other alternatives, such as hexamethylene-diisocynate
(HMDIC), also link amide groups, but without the same ability
to stabilize collagen networks.103 The size and chemistry of the
cross-linker can alter the scaﬀold properties independently of
the reaction eﬀectiveness. It was demonstrated on gas foamed
scaﬀolds that cross-linkers with long chains, that are incorporated
into the scaﬀold structure, for example HMDIC, increase water
absorption and elastic response.104
Fig. 4 Solute addition to 1 wt% insoluble collagen slurries changed the conformation of the molecule. In ionic solutions, the collagen conformation
changed, resulting in a lower viscosity of the slurry (a) than in non-ionic solute. Scaﬀolds were imaged with (b) no additions, (c) 0.5 wt% sucrose, and
(d) 0.5 wt% sodium chloride; scale bar is 100 mm. A highly fibrillar structure is visible with 0.5 wt% NaCl addition at higher magnifications: (e) 400 and
(f) 3300. Adapted from ref. 92.
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Not all cross-linkers are incorporated into the scaﬀold after
reacting. During dehydrothermal treatment (DHT), collagen
samples are heated to between 100–150 1C under vacuum, to
induce carboxylic and amine groups to react. With increasing
temperature, the cross-linking density increases. However,
temperatures above 150 1C have been shown to lead to denaturation
of the collagen, with levels reaching as high as 60% denaturation
as the temperature increases to 180 1C.105 A water soluble
carbodiimide, 1-ethyl-3-(3-dimethyl aminopropyl)carbodiimide
hydrochloride (EDC), also catalyzes a reaction between carboxylic
acids and amine groups, without being incorporated, lowering
potential cytotoxic effects due to the cross-linker itself.106
A key problem with comparisons between diﬀerent cross-
linking studies is that protocols often diﬀer greatly, which adds
variation between reported scaﬀold strengths. The most common
metric for characterizing cross-linking is via the overall mechanical
strength. However, some evaluation of the total number of cross-
links or even the ligand density remaining on the collagen material,
might provide a more reliable baseline for comparison.107 After
stabilization, collagen networks can have a significantly diﬀerent
number of cell adhesion ligands which aﬀects their in vivo perfor-
mance, Fig. 5(a).107 Aside from the cross-linking protocol, some of
the variation between studiesmay also be due to diﬀerent collagens
used as starting materials, as this has been shown to have a large
eﬀect on integrin ligand density and cross-linking eﬀectiveness.98
In order to optimize scaﬀold chemistry for regenerative medicine, a
focus on the underlying principles which drive cellular response
would be required. Increasing attention has been given to how
cross-linking aﬀects cellular reactions such as adhesion and
migration, as these are key to beginning repair during injury.
Preserving the ligands which communicate with cells is
extremely important. It has been shown, for example, that cross-
linkers which interfere with integrin ligands cause significant
decreases in cell attachment, proliferation and migration.98,109–111
In general, as the cross-linking strength increases, the cellular
response becomes less favorable, even in the absence of cytotoxic
effects due to the cross-linker itself. At EDC cross-linking strengths
of less than 10%what is normally used in literature, the attachment
of HT1080 cells increased by 5 times, and the scaffolds remained
stable in physiological conditions.98 Cellular proliferation is also
affected negatively by cross-linking protocols which maximize
mechanical strength.109,112 On collagen fibers, increases in
mechanical strength, as EDC concentration ranges from 0.25
to 25 mM, significantly decrease cell proliferation.109 The same
was shown to occur in collagen scaffolds. As EDC concentration
was increased from 6 mM to 96 mM, cell proliferation became
negligible.112 An inverse trend in fibroblast migration with
cross-linking strength was demonstrated, as well, when comparing
several different cross-linking methodologies.111 The cross-linking
which yielded the highest mechanical strength showed the least
migration of dermal fibroblasts across collagen fibers.111
Alternative cross-linking methods which do not rely on the
amino acids found in integrin ligands, might be a promising
way to optimize scaﬀold strength while retaining cell compatibility.
Eﬀorts to cross-link with UV have shown that ligands and cell
attachment are retained, even at the highest cross-linking
strengths tested, Fig. 5.108 UV cross-linking relies on the reaction
of aromatic groups, namely tyrosine and phenylalanine, after the
exposure to light in the UV range, around 245 nm.113 A trade-oﬀ
is made between increasing mechanical strength and degradation
of the collagen fibers.101,114 Enzyme mediated cross-linking is
also possible. Transglutaminase, an enzyme similar to LOX, has
been shown to alter D spacing in collagen fibers, and further to
up-regulate integrin subunits b1 and b3.
115,116 Copper ions have
also been found to function as a cross-linker on collagen fibrils.
After reacting copper with the collagen, the network had enhanced
protease resistance without changing the structure.117 Another
tack is to use self cross-linking systems.18,118 In the case of collagen
and chitosan, blends can achieve the same stability through
internal chemical reactions as they can through the use of
chemical cross-linkers.18 Finally, cross-linking via peptides is
another route, allowing diﬀerent functionality to be built in,
including ligands for collagenase (MMP sequences). This strategy
has been shown to be able to control migration of cells indepen-
dently of the total number of cross-linkers.119 However, as an
emerging field of tailored cross-linking, there remains many
avenues of exploration for peptide cross-linkers.120 All of the
methods above react in ways which do not eliminate vital
ligands for cell culture and proliferation, while still creating
mechanically stable scaﬀolds.
Another promising area of research is reintroducing ligand
sequences into cross-linked collagen structures. It has been
Fig. 5 Cross-linking type and amount influences the integrin ligands available for binding. (a) Ligand density of collagen scaﬀolds after cross-linking
with DHT (120 1C, 48 hours), and EDC (14.4 mM EDC). Modified from ref. 107. (b) Amine groups in collagen scaﬀolds after EDC cross-linking (100% refers
to 11.5 mgml1 EDC) and UV treatment (in J cm2). At high amine content, it is more likely that the GFOGER sequence remains unaltered. Adapted from ref. 108.
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demonstrated that peptides, containing sequences for integrin
binding, can up-regulate cell binding and adhesion, especially
if they have a native conformation, like cyclic RGD.80 By
reintroducing the integrin ligand GFOGER into an EDC cross-
linked scaﬀold, a recent study showed significant improvement
in cell attachment and spreading for several cell types, Fig. 6.121
By tailoring the peptide attachment site, the addition could be
localized and controlled as a further means of tailoring the
structure.121 This might be a major advance to overcome the
negative aﬀects inherent in many cross-linking processes.
Despite improvements in mechanical properties with cross-
linking, collagen materials remain very soft networks. With the
competing forces of stability and cell response, it would be well
worth considering individual applications for collagen scaﬀolds,
to determine the properties which are most needed. If a small
gain in mechanical strength does not greatly improve the
function of the construct, then it might be best to decrease
the cross-linking to optimize cellular signalling instead. However,
new methods of stabilizing the collagen networks are emerging,
such as ions or self cross-linking polymer systems, which have yet
to be fully explored. Also, the possibility of reintroducing integrin
ligands into the collagen network, may finally overcome the
conflict between mechanics and chemistry.
5. Conclusions
Collagen networks are one of the cornerstones of regenerative
medicine. Building collagen networks relies on a multi-step
process of fibrillogenesis, which is sensitive to the properties of
its environment. The most promising ways to alter collagen
structure during fibrillogenesis include: changing the pH, the
ionic strength of the solution, or the amino acid sequence of
the collagen molecule itself. Biological activity of collagen is
mediated through integrin receptors, which interact with the
high aﬃnity ligand, GFOGER, on the helical collagen fiber.
During scaﬀold production, collagen chemistry can be altered
either before the network is formed, or after scaﬀold formation.
Regardless of which stage collagen chemistry is altered, the
biological response is aﬀected. A key point emerging from
literature is the importance of preserving ligand sites along
the collagen chain to ensure that biocompatibility is not lost
during scaﬀold production. The ability to reintroduce integrin
ligands, into a cross-linked structure, has recently opened up
new avenues for controlling cell behavior on collagen networks.
Consideration of the collagen structure and chemistry, inherent
to collagen scaﬀolds, is a promising area for further exploration.
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